← Back to Search

Diagnostic Test

Treatment for Colorectal Cancer (ECLIPSE Trial)

N/A
Waitlist Available
Led By Kathryn Lang, MBBS MRCP
Research Sponsored by Guardant Health, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 60 days
Awards & highlights

Summary

This trial looks at a new blood test to detect colorectal cancer in people without symptoms. The test is non-invasive and may be more effective than current screening methods.

Eligible Conditions
  • Colorectal Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~60 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 60 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Sensitivity of colorectal cancer detection
Neoplasms
Secondary outcome measures
Negative predictive value of colorectal cancer detection
Positive predictive value of colorectal cancer detection
Adenoma

Find a Location

Who is running the clinical trial?

Guardant Health, Inc.Lead Sponsor
20 Previous Clinical Trials
16,115 Total Patients Enrolled
Premier Research Group plcIndustry Sponsor
62 Previous Clinical Trials
29,375 Total Patients Enrolled
Kathryn Lang, MBBS MRCPPrincipal InvestigatorGUARDANT HEALTH
~7516 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top